United Kingdom

People: Regeneron Pharmaceuticals Inc (REGN.OQ)

REGN.OQ on NASDAQ Stock Exchange Global Select Market

19 Oct 2018
Change (% chg)

$-5.39 (-1.36%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Van Plew, Daniel 

Mr. Daniel P. Van Plew is an Executive Vice President, General Manager - Industrial Operations and Product Supply of the Company. Mr. Van Plew served as Senior Vice President and General Manager, Industrial Operations and Product Supply. Prior to that date, he served as Vice President and General Manager, Industrial Operations and Product Supply since joining the Company in 2007. From 2006 until 2007, Mr. Van Plew served as Executive Vice President, R&D and Technical Operations of Crucell Holland B.V., a global biopharmaceutical company. Between 2004 and 2006, Mr. Van Plew held positions of increasing responsibility at Chiron Biopharmaceuticals, part of Chiron Corporation, a biotechnology company, most recently as Senior Director, Vacaville Operations. From 1998 until 2004, Mr. Van Plew held various managerial positions in the health and life sciences practice at Accenture, Ltd., a management consulting business. Mr. Van Plew received his M.S. in Chemistry from The Pennsylvania State University and his M.B.A. from Michigan State University.

Basic Compensation

Total Annual Compensation, USD 560,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 8,418,600
Fiscal Year Total, USD 8,978,600

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

P. Roy Vagelos


Leonard Schleifer


Robert Landry


Daniel Van Plew


Neil Stahl


Joseph LaRosa

As Of  31 Dec 2017